Parallax Volatility Advisers, L.P. Arrowhead Pharmaceuticals, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $1.41 Million - $2.33 Million	81,000 Added 184.09%	125,000 $3.31 Million
Q1 2019 May 15, 2019	SELL	$12.05 - $20.18 $72,300 - $121,080	-6,000 Reduced 12.0%	44,000 $808,000
Q4 2018 Feb 14, 2019	SELL	$10.74 - $19.7 $322,200 - $591,000	-30,000 Reduced 37.5%	50,000 $621,000
Q3 2018 Nov 14, 2018	BUY	$14.0 - $20.3 $1.12 Million - $1.62 Million	80,000 New	80,000 $1.53 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.